OGOREK ANTHONY JOSEPH /NY/ /ADV
Position in GILD — Gilead Sciences, Inc.
CIK 714364
WILLIAMSVILLE, NY
Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$58,495
-$6,033 QoQ
Shares Held
463
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,044
of 2,266 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OGOREK ANTHONY JOSEPH /NY/ /ADV holds $11,041,030 across 10 Drug Manufacturers - General names. GILD ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,159 | $9,786,150 | |
| 2 | ABBV |
AbbVie Inc.
|
1,878 | $472,579 | |
| 3 | JNJ |
Johnson & Johnson
|
1,205 | $306,033 | |
| 4 | AMGN |
Amgen Inc
|
372 | $134,708 | |
| 5 | MRK |
Merck & Co., Inc.
|
980 | $125,930 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392 | $80,207 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
463 | $58,495 | |
| 8 | BIIB |
Biogen Inc.
|
152 | $32,841 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,495 | 463 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $64,528 | 463 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $56,705 | 462 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $60,717 | 547 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $59,980 | 541 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $61,291 | 547 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $29,281 | 317 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $33,032 | 394 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $26,963 | 393 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $47,466 | 648 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $65,699 | 811 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,696,341 | 35,980 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $2,779,606 | 36,066 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $3,399,695 | 40,975 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,952,705 | 46,042 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $2,854,087 | 46,265 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,837,388 | 45,905 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $2,658,544 | 44,719 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $2,794,613 | 38,488 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,686,570 | 38,462 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $2,648,011 | 38,455 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $2,418,131 | 37,415 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,596,090 | 27,396 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,673,650 | 26,486 | Shares | Sole | 2020-11-02 | |
| No filing history on record for this holder in this stock. | ||||||